Impressed by ⁦⁦John Fetterman⁩ to speak out about his own major depressive episode. You save lives! podcasts.apple.com/se/podcast/nbc…

Did Eiko Fried have any reflections seeing Fredrik Hieronymus ‘s more specific concerns? I can’t find them.

Valuable data. Well Done JAMA Psychiatry

A silent bell tolls no warning. Read our comment jamanetwork-com.proxy.kib.ki.se/journals/jamap… on the interesting risk for switch study jamanetwork-com.proxy.kib.ki.se/journals/jamap… by Suvi Virtanen et al. Dr. Adrian Boström Fredrik Hieronymus Mikael Landen

Ny översikt om psykedelikaforskning på svenska rekommenderas av @epikrisa!

Tack. Min personliga erfarenhet är ingen märkbar skillnad i tryck från avsändarna av de medel jag via KI och SLSO förfogar över för forskning inom det här området (VR (största finansiär), Cancerfonden, privat donation). Men allmänt viktig fråga ju Christian Rück.

New Research Group Leader and HR.

New paper in JAMA Psychiatry by Dr. Adrian Boström et al on the progression from #MDD to BD in adolescents and adults. We suggest that adolescents experience delayed BD progression and that diagnosis is associated with a substantial reduction in inpatient care. jamanetwork.com/journals/jamap…

🚨 New Study in JAMA Psychiatry! 🚨 Adolescents with first episode depression who are later diagnosed with bipolar disorder (BD) are 50% less likely to receive an early BD diagnosis compared to adults. Substantial reduction in inpatient care observed for all ages post-BD

Still fascinating results based on >2000000 person years of data

Feel free to check out our new paper written by my colleague Anna Gannedahl showing an impact of socioeconomic status on depression care in a sample of over 100 000 patients. pubmed.ncbi.nlm.nih.gov/38914164/

Please read and share within your networks! I do think this is a rare and great opportunity for the right applicant!

Does psilocybin really provide long-term relief from depression, as new study suggests? theconversation.com/does-psilocybi… via The Conversation

The Ames Test offered a fast and inexpensive way to identify carcinogens, leading to the banning of chemicals linked to cancer and birth defects. nyti.ms/40a1tcV

Curious on #psychedelics, #Neuroscience and #clinicaltrials ? Register for the first of three webinars hosted by Karolinska Institutet and ECNP on February 7 at 1 pm CET at news.ki.se/a-european-per…

Don’t miss out! linkedin.com/posts/european…

Thrilled to be able to report that there are now grant opportunities available for students at Canadian post-secondary institutions looking to investigate Post-SSRI Sexual Dysfunction! shapehub.ca/shape-trainee-…

Patients receiving control treatments in psilocybin trials showed less improvement in depression outcomes compared to those in SSRI or esketamine trials. ja.ma/3U5IQCz

Great summary and discussion Fredrik Hieronymus